Predictive Oncology Operating Margin 2010-2025 | POAI

Predictive Oncology operating margin from 2010 to 2025. Operating margin can be defined as operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc.

Predictive Oncology Operating Margin 2010-2025 | POAI

Predictive Oncology operating margin from 2010 to 2025. Operating margin can be defined as operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$46.1B
Tempus AI (TEM)$13.3B
Doximity (DOCS)$12B
Hims & Hers Health (HIMS)$9.9B
IRhythm Technologies (IRTC)$5.4B
Hinge Health (HNGE)$4.4B
Inspire Medical Systems (INSP)$2.7B
Privia Health (PRVA)$2.6B
Heartflow (HTFL)$2.3B
Phreesia (PHR)$1.7B
Enovis (ENOV)$1.7B
10x Genomics (TXG)$1.6B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.3B
Claritev (CTEV)$1.1B
Evolent Health (EVH)$1B
Fulgent Genetics (FLGT)$655M
Zepp Health (ZEPP)$580M
Veradigm (MDRX)$525M
Standard BioTools (LAB)$458M
Talkspace (TALK)$456M
Butterfly Network (BFLY)$350M
Carlsmed (CARL)$342M
TruBridge (TBRG)$296M
Outset Medical (OM)$243M
SOPHiA GENETICS SA (SOPH)$232M
Nyxoah SA (NYXH)$216M
Health Catalyst (HCAT)$215M